Article
Sleep Measured by Polysomnography in Patients Receiving High-Dose Chemotherapy for Multiple Myeloma Prior to Stem Cell Transplantation
Purpose/Objectives: To describe the objective sleep of patients receiving chemotherapy for multiple myeloma (MM) prior to stem cell transplantation.
Design: A descriptive study with repeated measures.
Setting: An international referral center in an urban area of the southern United States.
Sample: A convenience sample of a subset of 12 patients with MM, recruited from a randomized, controlled trial.
Methods: Objective sleep was assessed using two nights of polysomnography, one obtained before and one after a second cycle of high-dose chemotherapy prior to stem cell transplantation. Demographic and clinical data were obtained through a retrospective chart review.
Main Research Variables: Objective sleep including sleep characteristics, sleep-related respiratory events, and periodic limb movements (PLMs) of sleep.
Findings: Sleep was characterized by a relatively short sleep time, excessive time spent awake after the onset of sleep, and poor sleep efficiency (objective sleep quality). Patients spent more than the expected percent of time in non-rapid eye movement sleep and less in rapid eye movement sleep. Arterial oxyhemoglobin saturation nadirs reflected episodes of low arterial oxygen saturation. PLMs during sleep were in the mildly elevated range.
Conclusions: Findings suggest that patients had poor sleep efficiency (objective sleep quality) and were slightly better sleepers after receiving a second cycle of high-dose chemotherapy. A number of patients also demonstrated obstructive sleep apnea and frequent PLMs.
Implications for Nursing: Findings support the need for additional investigation of sleep in patients with MM, particularly poor sleep efficiency and PLMs. Improving sleep may improve quality of life by decreasing associated symptoms such as pain, fatigue, and depression.
Knowledge Translation: Oncology nurses should consider assessing patients with MM for insomnia symptoms, excessive daytime sleepiness, obstructive sleep apnea, and a history of jerking or kicking their legs when asleep. Those symptoms may suggest the need for additional investigation of a possible sleep disorder, which may negatively influence mood and function.
Jump to a section
References
Allen, R. P., Barker, P. B., Wehrl, F., Song, H. K., & Earley, C. J. (2001). MRI measurement of brain iron in patients with restless legs syndrome. Neurology, 56, 2263-2265.
Allen, R. P., & Earley, C. J. (2007). The role of iron in restless legs syndrome. Movement Disorders, 22(Suppl. 18), S440-S448. doi:10.1002/mds.21607
American Sleep Disorders Association and Sleep Research Society Report. (1992). EEG arousals: Scoring rules and examples. Sleep, 15, 173-184.
Ancoli-Israel, S., Kripke, D. F., Klauber, M. R., Mason, W. J., Fell, R., & Kaplan O. (1991a). Periodic limb movements in sleep in community-dwelling elderly. Sleep, 14, 496-500.
Ancoli-Israel, S., Kripke, D. F., Klauber, M. R., Mason, W. J., Fell, R., & Kaplan, O. (1991b). Sleep-disordered breathing in community-dwelling elderly. Sleep, 14, 486-495.
Berenson, J. R. (Ed.). (2005). Biology and management of multiple myeloma. Totowa, NJ: Humana Press.
Berger, A. M. (2009). Update on the state of the science: Sleep-wake disturbances in adult patients with cancer [Online exclusive]. Oncology Nursing Forum, 36, E165-E177.
Berger, A. M., Parker, K. P., Young-McCaughan, S., Mallory, G. A., Barsevick, A. M., Beck, S. L., … Hall, M. (2005). Sleep wake disturbances in people with cancer and their caregivers: State of the science [Online exclusive]. Oncology Nursing Forum, 32, E98-E126. doi:10.1188/05.ONF.E98-E126
Berry, R. B. (2012). Fundamentals of sleep medicine. Philadelphia, PA: Elsevier.
Bixler, E. O., Vgontzas, A. N., Ten Have, T., Tyson, K., & Kales, A. (1998). Effects of age on sleep apnea in men: Prevalence and severity. American Journal of Respiratory and Critical Care Medicine, 157(1), 144-148.
Bliwise, D., Petta, D., Seidel, W., & Dement, W. (1985). Periodic leg movements during sleep in the elderly. Archives of Gerontology and Geriatrics, 4, 273-281.
Borbély, A. A. (1982). A two process model of sleep regulation. Human Neurobiology, 1, 195-204.
Carskadon, M. A., & Dement, W. C. (2005). Normal human sleep: An overview. In M. H. Kryger, T. Roth, & W. C. Dement (Eds.), Principles and practice of sleep medicine (pp. 13-23). Philadelphia, PA: Elsevier.
Celgene Corporation. (2006). Thalomid (thalidomide) [Package insert]. Summit, NJ: Author.
Chaudhry, V., Combiath, D. R., Polydefkis, M., Ferguson, A., & Borrello, I. (2008). Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy. Journal of the Peripheral Nervous System, 13, 275-282. doi:10.1111/j.1529-8027.2008.00193.x
Chervin, R. D., Archbold, K. H., Dillon, J. E., Pituch, K. J., Panahi, P., Dahl, R. E., & Guilleminault, C. (2002). Associations between inattention, hyperactivity, restless legs and periodic leg movements. Sleep, 25, 213-218.
Coleman, E. A., Goodwin, J. A., Coon, S. K., Richards, K., Enderlin, C., Kennedy, R., … Barlogie, B. (2010). Fatigue, sleep, pain, mood, and performance status in patients with multiple myeloma. Cancer Nursing, 34, 219-227. doi:10.1097/NCC.0b013e3181f9904d
Collop, N. A. (2006). Polysomnography. In T. Lee-Chiong (Ed.), Sleep: A comprehensive handbook (pp. 973-976). Hoboken, NJ: Wiley-Liss.
Davidson, J. R., Maclean, A. W., Brundage, M. D., & Schulze, K. (2002). Sleep disturbance in cancer patients. Social Science and Medicine, 54, 1309-1321. doi:10.1016/S0277-9536(01)00043-0
Delforge, M., Bladé, J., Dimopoulos, M. A., Facon, T., Kropff, M., Ludwig, H., … Sonneveld, P. (2010). Treatment-related peripheral neuropathy in multiple myeloma: The challenge continues. Lancet Oncology, 11, 1086-1095. doi:10.1016/S1470-2045(10)70068-1
Dement, W. C. (2011). History of sleep physiology and medicine. In M. H. Kryger, T. Roth, & W. C. Dement (Eds.), Principles and practice of sleep medicine (5th ed., pp. 3-15). Philadelphia, PA: Saunders.
Dimopoulos, M. A., Kastritis, E., Rosinol, L., Blade, J., & Ludwig, H. (2008). Pathogenesis and treatment of renal failure in multiple myeloma. Leukemia, 22, 1495-1493. doi:10.1038/leu.2008.131
Drug Information Online. (2012a). Enalapril. Retrieved from http://www.drugs.com/enalapril.html
Drug Information Online. (2012b). Fentanyl side effects. Retrieved from http://www.drugs.com/sfx/fentanyl-side-effects.html
Drug Information Online. (2012c). Levothyroxine side effects. Retrieved from http://www.drugs.com/sfx/levothyroxine-side-effects.html
Drug Information Online. (2012d). Lorazepam side effects. Retrieved from http://www.drugs.com/sfx/lorazepam-side-effects.html
Drug Information Online. (2012e). Metoprolol side effects. Retrieved from http://www.drugs.com/sfx/metoprolol-side-effects.html
El-Cheikh, J., Stoppa, A. M., Bouabdallah, R., de Lavallade, H., Coso, D., de Collela, J. M., … Mohty, M. (2008). Features and risk factors of peripheral neuropathy during treatment with bortezomib for advanced multiple myeloma. Clinical Lymphoma and Myeloma, 8, 146-152. doi:10.3816/CLM.2008.n.017
Exar, E. N., & Collop, N. A. (2001). The association of upper airway resistance with periodic limb movements. Sleep, 24, 188-192.
Faiman, B., Bilotti, E., Mangan, P. A., & Rogers, K. (2008). Steroid-associated side effects in patients with multiple myeloma: Consensus statement of the IMF Nurse leadership Board. Clinical Journal of Oncology Nursing, 12(3, Suppl.), 53-63.
Gemignani, F., Brindani, F., Negrotti, A., Vitetta, F., Alfieri, S., Marbini, A. (2006). Restless legs syndrome and polyneuropathy. Movement Disorders, 21, 1254-1257. doi:10.1002/mds.20928
Hoque, R., & Chesson, A. L. (2010). Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: Literature review, qualitative scoring, and comparative analysis. Journal of Clinical Sleep Medicine, 6, 79-83.
Hornyak, M., & Trenkwalder, C. (2004). Restless legs syndrome and periodic limb movement disorder in the elderly. Journal of Psychosomatic Research, 56, 543-548.
Karadeniz, D., Ondze, B., Besset, A., & Billiard, M. (2000). Are periodic leg movements during sleep (PLMS) responsible for sleep disruption in insomnia patients? European Journal of Neurology, 7, 331-336.
Kryger, M., Monjan, A., Bliwise, D., & Ancoli-Israel, S. (2004). Sleep, health, and aging. Bridging the gap between science and clinical practice. Geriatrics, 59, 24-30.
Lee, K. A. (2003). Impaired sleep. In V. Carrieri-Kohlman, A. Lindsey, & C. West (Eds.), Pathophysiological phenomena in nursing (3rd ed., pp. 363-385). St. Louis, MO: Saunders.
Ludwig, H., & Osterborg, A. (2010). Pathogenesis and treatment of anemia. In J. R. Berenson (Ed.), Biology and management of multiple myeloma (pp. 303-318). Totowa, NJ: Humana.
Mangan, P. (2005). Recognizing multiple myeloma. Nurse Practitioner, 30(3), 14-27.
National Cancer Institute. (2012). Multiple myeloma/other plasma cell enoplasms. Retrieved from http://www.cancer.gov/cancertopics/types/myeloma
National Center on Sleep Disorders Research. (n.d.). National sleep disorders research plan, section 5: Restless legs syndrome/ periodic limb movement disorder. Retrieved from http://www.nhlbi.nih.gov/health/prof/sleep/res_plan/section5/section5d.html
Niscola, P., Scaramucci, L., Romani, C., Giovannini, M., Maurillo, L., del Poeta, G., … De Fabritiis, P. (2006). Opioids in pain management of blood-related malignancies. Annals of Hematology, 85, 489-501.
Palumbo, A., Facon, T., Sonneveld, P., Bladè, J., Offidani, M., Gay, F., … Harousseau, J. L. (2008). Thalidomide for treatment of multiple myeloma: 10 years later. Blood, 111, 3968-3977. doi:10.1182/blood-2007-10-117457
Phillips, K. M., Jim, H. S., Donovan, K. A., Pinder-Schenck, M. C., & Jacobsen, P. B. (2012). Characteristics and correlates of sleep disturbances in cancer patients. Supportive Care in Cancer, 20, 357-365. doi:10.1007/s00520-011-1106-z
Punjabi, N. M. (2008). The epidemiology of adult obstructive sleep apnea. Proceedings of the American Thoracic Society, 5, 136-143. doi:10.1513/pats.200709-155MG
Qureshi, A. R. A. (2008). Medications: Therapeutic and Adverse Effects on Sleep Pulmonary Critical Care and Sleep Update (PCCSU) article. Retrieved from http://www.chestnet.org/accp/pccsu/medications-therapeutic-and-adverse-effects-sleep?page=0,3
Rechtschaffen, A., & Kales, A. (1968). A manual of standardized terminology, techniques and scoring systems for sleep stages of human subjects [Public Health Service Publication No. 204]. Washington, DC: U. S. Government Printing Office.
Rome, S. (2010). Patient teaching. In J. D. Tariman (Ed.), Multiple myeloma: A textbook for nurses (pp. 195-229). Pittsburgh, PA: Oncology Nursing Society.
Sateia, M. J., & Lang, B. J. (2008). Sleep and cancer: Recent developments. Current Oncology Reports, 10, 309-318. doi:10.1007/s11912-008-0049-0
Savard, J., Ivers, H., Villa, J., Caplette-Gingras, A., & Morin, C. M. (2011). Natural course of insomnia comorbid with cancer: An 18-month longitudinal study. Journal of Clinical Oncology. Advance online publication. doi:10.1200/JCO.2010.33.2247
Scheer, F., & Shea, S. A. (2009). Fundamentals of the circadian system. In C. J. Amlaner & P. M. Fuller (Eds.), Basics of sleep guide (2nd ed., pp. 199-221). Westchester, IL: Sleep Research Society.
Sharma, N., Hansen, C. H., O'Connor, M., Thekkumpurath, P., Walker, J., Kleiboer, A., … Sharpe, M. (2011). Sleep problems in cancer patients: Prevalence and association with distress and pain. Psycho-Oncology, 21, 1003-1009. doi:10.1002/pon.2004.
Sherman, A. C., Simonton, S., Latif, U., Plante, T. G. & Anaissie, E. J. (2009). Changes in quality-of-life and psychosocial adjustment among multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation. Biology of Blood and Bone Marrow Transplantation, 15, 12-20. doi:10.1016/j.bbmt.2008.09.023
Snowden, J. A., Ahmedzai, S. H., Ashcroft, J., D'Sa, S., Littlewood, T., Low, E., … Haemato-oncology Task Force of the British Committee for Standards in Haematology and UK Myeloma Forum. (2011). Guidelines for supportive care in multiple myeloma 2011. British Journal of Haematology, 154, 76-103. doi:10.1111/j.1365-2141.2011.08574.x
Soloman, A., Weiss, D. T., & Herrera, G. A. (2010). Renal diseases associated with multiple myeloma and related plasma cell dysplasias. In J. R. Berenson (Ed.), Biology and management of multiple myeloma (pp. 281-302). Totowa, NJ: Humana.
Swedko, P. J., Clark, H. D., Paramsothy, K., & Akbari, A. (2003). Serum creatinine is an inadequate screening test for renal failure in elderly patients. Archives of Internal Medicine, 163, 356-360. doi:10.1001/archinte.163.3.356
Trenkwalder, C., Walters, A. S., & Hening, W. (1996). Periodic limb movements and restless legs syndrome. Neurologic Clinics, 14, 629-650.
Tyron, W. W. (1991). Activity measurement in psychology and medicine. New York, NY: Plenum.
Van Cauter, E. V., & Allostatic Load Working Group. (1997). Sleep qualityand endocrine markers of sleep quality. Retrieved from http://www.macses.ucsf.edu/research/allostatic/sleep.php
Vena, C., Parker, K., Cunningham, M., Clark, J., & McMillan, S. (2004). Sleep-wake disturbances in people with cancer part 1: An overview of sleep, sleep regulation, and effects of disease and treatment. Oncology Nursing Forum, 31, 735-746. doi:10.1188/04.ONF.735-746
Youngstedt, S. D., Kripke, D. F., Klauber, M. R., Sepulveda, R. S., & Mason, W. J. (1998). Periodic leg movements during sleep and sleep disturbances in elders. Journals of Gerontology, 53, M391-M394.